CiNii Articles - bevacizumab

1

Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with Apixaban

Fujiwara Yu , Yamaguchi Takeshi , Nakane Minoru

… A 70-year-old Asian man was diagnosed with PVT two months after initiating 5-fluorouracil/leucovorin, irinotecan, and bevacizumab therapy for rectal cancer with liver metastases. … Because the metastases were small and shrinking, we suspected that the thrombosis might have been caused by bevacizumab-containing chemotherapy. … We stopped bevacizumab and started apixaban, a direct oral anticoagulant (DOAC). …

Internal Medicine 60(1), 53-57, 2021

J-STAGE
2

Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma [in Japanese]

葛谷貞二 , 川部直人 , 廣岡芳樹

消化器・肝臓内科 = Gastroenterology & hepatology 8(5), 494-501, 2020-11
3

Cancer drug therapy guidelines for the elderly CQ6 [in Japanese]

柏田知美

腫瘍内科 = Clinical oncology 26(5), 496-501, 2020-11
4

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review

Maeda Osamu , Ohka Fumiharu , Maesawa Satoshi , Matsuoka Ayumu , Shimokata Tomoya , Mitsuma Ayako , Urakawa Hiroshi , Nakamura Shota , Shimoyama Yoshie , Nakaguro Masato , Wakabayashi Toshihiko , Ando Yuichi

… Although standard chemotherapy for SHT/HPC has not been established, temozolomide plus bevacizumab (TMZ+Bev) therapy for SFT/HPC has been reported. … The effectiveness and safety of TMZ+Bev (temo-zolomide 150 mg/m2 orally on days 1–7 and days 15–21 and bevacizumab 5 mg/kg intravenously on day 8 and day 22 on a 28-day cycle), which was administered from December 2013 until April 2019 to four patients with SFT/HPC, were retrospectively analyzed. …

Nagoya Journal of Medical Science 82(4), 631-644, 2020-11

IR DOI
5

A case of black necrosis in the fingers during chemotherapy combined with bevacizumab for ovarian cancer [in Japanese]

久保倉優香 , 松永竜也 , 萩原真由美 , 飯島崇善 , 紙谷菜津子 , 祐森明日菜 , 永田亮 , 今井雄一 , 水島大一 , ルイズ横田奈朋 , 倉澤健太郎 , 中村朋美 , 宮城悦子

神奈川産科婦人科学会誌 = Kanagawa journal of obstetrics and gynecology : official journal, Kanagawa Society of Obstetrics and Gynecology 57(1), 20-24, 2020-09
6

Modified guidelines for treatment of ovarian cancer [in Japanese]

河村美由紀 , 松本光史

腫瘍内科 = Clinical oncology 26(3), 297-304, 2020-09
7

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐RAS status for unresectable colorectal liver metastasis (BECK study): Long‐term results of survival

Okuno Masayuki , Hatano Etsuro , Toda Rei , Nishino Hiroto , Nakamura Kojiro , Ishii Takamichi , Seo Satoru , Taura Kojiro , Yasuchika Kentaro , Yazawa Takefumi , Zaima Masazumi , Kanazawa Akiyoshi , Terajima Hiroaki , Kaihara Satoshi , Adachi Yukihito , Inoue Naoya , Furumoto Katsuyoshi , Manaka Dai , Tokuka Atsuo , Furuyama Hiroaki , Doi Koji , Hirose Tetsuro , Horimatsu Takahiro , Hasegawa Suguru , Matsumoto Shigemi , Sakai Yoshiharu , Uemoto Shinji

… [Results]A total of 22/12 patients with K‐RAS wild‐type/mutant tumors were treated with mFOLFOX6 + cetuximab/bevacizumab. …

Journal of hepato-biliary-pancreatic sciences 27(8), 496-509, 2020-08

IR
8

Bevacizumab combination chemotherapy for non-squamous cell cervical carcinoma [in Japanese]

馬場慎司 , 伊田勉 , 栗山真侑 , 郡悠介 , 有山悠乃 , 齋藤茉祐子 , 大城早紀子 , 高原めぐみ , 中村浩敬 , 本多泉 , 谷口義実 , 光山聡

東京産科婦人科学会会誌 69(3), 417-421, 2020-07

Ichushi Web
9

Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma [in Japanese]

月刊薬事 = The pharmaceuticals monthly 62(9), 1856-1858, 2020-07
10

Impact on combination therapy of atezolizumab and bevacizumab for unresectable hepatocellular carcinoma [in Japanese]

大鶴徹 , 池田公史

医学のあゆみ 273(13), 1221-1226, 2020-06-27
11

A CASE OF AN ELDERLY PATIENT WITH BRAF GENE MUTANT UNRESECTABLE RECURRENT COLORECTAL CANCER TREATED EFFECTIVELY WITH FOLFOXIRI PLUS BEVACIZUMAB [in Japanese]

橋本和晃 , 中野昌彦 , 片桐侑里子 , 平川雄介 , 勝本充 , 友枝博 , 柳克司

久留米医学会雑誌 83(6), 148-156, 2020-06

Ichushi Web
12

Course for Medical Oncologist : Prep test for medical oncologist(122)answer and explanation [in Japanese]

谷本梓

腫瘍内科 = Clinical oncology 25(6), 687-689, 2020-06
13

A case of extensive leg erosion associated with erlotinib and bevacizumab treatment [in Japanese]

鹿毛勇太 , 袋幸平 , 大須賀裕子 , 泉佳菜子 , 中村和子 , 蒲原毅

臨床皮膚科 = Japanese journal of clinical dermatology 74(6), 389-394, 2020-05

Ichushi Web
14

Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation

Tanaka Ichidai , Morise Masahiro , Miyazawa Ayako , Kodama Yuta , Tamiya Yutaro , Gen Soei , Matsui Akira , Hase Tetsunari , Hashimoto Naozumi , Sato Mitsuo , Hasegawa Yoshinori

… However, the clinical benefits of bevacizumab plus cytotoxic chemotherapy for EGFR mutation–positive patients remain unclear. … This study aimed to investigate VEGFA messenger RNA expression in patients with EGFR mutation, and to further compare the efficacy of bevacizumab combined with platinum-based chemotherapy between EGFR-mutant and wild-type patients. … n = 104) or bevacizumab plus CPem (BevCPem; …

Clinical Lung Cancer 21(3), 273-280.e4, 2020-05

IR
15

Recurrent high-grade neuroendocrine carcinoma of the uterine cervix responding to combination therapy with paclitaxel, carboplatin, and bevacizumab : A case report [in Japanese]

津田聡 , 高橋一彰 , 竹中将貴 , 小田嶋俊 , 川畑絢子 , 關壽之 , 鈴木二郎 , 上田和 , 柳田聡 , 矢内原臨 , 山田恭輔 , 岡本愛光

東京産科婦人科学会会誌 69(2), 258-264, 2020-04

Ichushi Web
16

Radiotherapy with intravitreal bevacizumab injection was effective in a case of breast cancer metastatic to the choroid [in Japanese]

高綱陽子 , 千葉晃大 , 安藤貴章 , 石井奈津美 , 笠川隆玄 , 安田茂雄 , 北橋正康 , 馬場隆之 , 山本修一

臨床眼科 74(3), 277-282, 2020-03
17

Low-dose bevacizumab did not reduce epistaxis in patient with hereditary hemorrhagic telangiectasia : a case report

Yamauchi Tomohiko , Utano Kenichi , Tsunoda Saburo , Yokoyama Shuji , Ogawa Hiroshi

… To control both epistaxis and melena, off-label administration of bevacizumab was planned and approved by the ethical committee at Fukushima Medical University. … However, after three courses of low-dose bevacizumab （2 mg/kg, every 3 weeks）, the frequency of epistaxis and melena were not reduced. … Thus, bevacizumab administration was discontinued. …

自治医科大学紀要 = Jichi Medical University Journal (42), 19-23, 2020-03

IR Ichushi Web
18

Onco-cardiology : focus on hypertension [in Japanese]

石田純一 , 赤澤宏

日本臨床 = Japanese journal of clinical medicine 78(2), 342-347, 2020-02
19

The usefulness of double-balloon enteroscopy for colonic stent placement: A case report [in Japanese]

Ogawa Yutaro , Iwai Takuma , Takeda Kohki , Ueda Koji , Kuriyama Sho , Miyasaka Toshimitsu , Yoshida Hiroshi , Matsuda Akihisa , Yamada Takeshi , Omori Jun , Hoshimoto Aitoshi , Shinji Seiichi , Sonoda Hiromichi , Ohta Ryo , Takahashi Goro

… Systemic chemotherapy with bevacizumab was introduced after a good postoperative course. …

Progress of Digestive Endoscopy 97(1), 125-127, 2020

J-STAGE
20

A Case of Acute Onset Type 1 Diabetes Diagnosed After the Development of Diabetic Ketoacidosis Following the Administration of Atezolizumab [in Japanese]

Inoue Chisa , Kokubo Ryota , Uemura Mei , Suzuki Toshinari , Gabazza Esteban C. , Yano Yutaka , Nishihama Kota , Nakahara Hiroki , Okano Yuko , Tanaka Soichiro , Yoshihara Akihiro , Uchida Akihiro , Maki Kanako , Eguchi Kazuhito

… This was followed by the combination of carboplatin, pemetrexed and bevacizumab, monotherapy by atezolizumab and monotherapy by docetaxel therapy. …

Journal of the Japan Diabetes Society 63(12), 811-819, 2020

J-STAGE

Search Results 1-20 of 1109

Related Authors

Related Journals